Long-term outcome of patients who are alive and well two years after allografting for acute leukemia.

被引：0
|
作者：
Mehta, J [1 ]
Powles, R [1 ]
Treleaven, J [1 ]
Kulkarni, S [1 ]
Horton, C [1 ]
Tait, D [1 ]
Singhal, S [1 ]
机构：
[1] ROYAL MARSDEN HOSP,SURREY,ENGLAND
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1692 / 1692
页数：1
相关论文
共 50 条
  • [1] Long-term outcome of patients who are alive and well two years after allografting for acute leukaemia.
    Mehta, J
    Powles, R
    Treleaven, T
    Kulkarni, S
    Horton, C
    Tait, D
    Singhal, S
    BONE MARROW TRANSPLANTATION, 1998, 21 : S7 - S7
  • [2] Long-term outcome of patients who are alive and well two years after autografting for acute leukaemia.
    Treleaven, J
    Powles, R
    Singhal, S
    Kulkarni, S
    Tait, D
    Horton, C
    Mehta, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S8 - S8
  • [3] Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation
    Singhal, S
    Powles, R
    Treleaven, J
    Kulkarni, S
    Horton, C
    Mehta, J
    BONE MARROW TRANSPLANTATION, 1999, 23 (09) : 875 - 879
  • [4] Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation
    S Singhal
    R Powles
    J Treleaven
    S Kulkarni
    C Horton
    J Mehta
    Bone Marrow Transplantation, 1999, 23 : 875 - 879
  • [5] Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling
    Singhal, S
    Powles, R
    Treleaven, J
    Kulkarni, S
    Horton, C
    Mehta, J
    LEUKEMIA & LYMPHOMA, 1999, 34 (3-4) : 287 - 294
  • [6] Long-term outcome of acute leukemia patients who are alive and well 2 years after allogeneic bone marrow transplantation (BMT) from partially mismatched related donors (PMRD).
    Henslee-Downey, PJ
    Godder, K
    Abhyankar, S
    Chiang, KY
    Bridges, K
    Adams, S
    Goon-Johnson, K
    Carpenter, S
    Foster, B
    Higgins-Smith, K
    van Rhee, F
    Christiansen, N
    Mehta, J
    BLOOD, 1999, 94 (10) : 568A - 569A
  • [7] Long term outcome of patients who are alive and in complete remission two years after allogeneic stem cell transplantation
    Worel, N
    Keil, F
    Kalhs, P
    Biener, D
    Mitterbauer, M
    Rabitsch, W
    Höcker, P
    Lechner, K
    Greinix, HT
    BONE MARROW TRANSPLANTATION, 2001, 27 : S223 - S223
  • [8] Long term outcome of patients who are alive and in complete remission two years after allogeneic stem cell transplantation.
    Worel, N
    Keil, F
    Kalhs, P
    Biener, D
    Mitterbauer, M
    Rabitsch, W
    Hoecker, P
    Lechner, K
    Greinix, H
    BLOOD, 2000, 96 (11) : 202A - 202A
  • [9] Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation
    Worel, N
    Biener, D
    Kalhs, P
    Mitterbauer, M
    Keil, F
    Schulenburg, A
    Höcker, P
    Dieckmann, K
    Fischer, G
    Rosenmayr, A
    Linkesch, W
    Hinterberger, W
    Lechner, K
    Greinix, HT
    BONE MARROW TRANSPLANTATION, 2002, 30 (09) : 619 - 626
  • [10] Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation
    N Worel
    D Biener
    P Kalhs
    M Mitterbauer
    F Keil
    A Schulenburg
    P Höcker
    K Dieckmann
    G Fischer
    A Rosenmayr
    W Linkesch
    W Hinterberger
    K Lechner
    HT Greinix
    Bone Marrow Transplantation, 2002, 30 : 619 - 626
12345